CYTOKINE EXPRESSION IN HUMAN PRIMARY AND METASTATIC MELANOMA-CELLS - ANALYSIS IN FRESH BIOPTIC SPECIMENS

被引:33
作者
CIOTTI, P [1 ]
RAINERO, ML [1 ]
NICOLO, G [1 ]
SPINA, B [1 ]
GARRE, C [1 ]
CASABONA, F [1 ]
SANTI, PL [1 ]
BIANCHISCARRA, G [1 ]
机构
[1] UNIV GENOA,INST BIOL & GENET,6 VIALE BENEDETTO XV,I-16126 GENOA,ITALY
关键词
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERLEUKIN; TUMOR PROGRESSION;
D O I
10.1097/00008390-199502000-00005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In recent years, several studies have documented that melanoma cell lines produce various cytokine/growth factors and their receptors. Since cell lines can acquire altered properties, such as changes in growth requirements, we studied constitutive cytokine gene expression in melanoma cells from 20 fresh surgical specimens: seven primary melanomas and 13 metastases (12 lymph-node metastases) and one subcutaneous metastasis). After tumor cell isolation by discontinuous gradient, we tested for mRNA expression by means of reverse-transcriptase polymerase chain reaction. Most melanoma cells tested expressed growth factors: basic fibroblast growth factor (bFGF), interleukin (IL) 1 alpha, IL-1beta, IL-6 and IL-8 and, in five cases out of 20, expressed granulocyte-macrophage colony-stimulating factor (GM-CSF) (two out of five were also positive for GM-CSF receptor). Our results do not point to a direct correlation between cytokine expression and clinical stage at the time when the bioptic specimen was obtained. However, they allow us to suggest a possible metastatic tumour cell phenotype, in which autogenous GM-CSF expression could modulate immune response against the tumour cell itself or could potentiate metastatic colonization properties.
引用
收藏
页码:41 / 47
页数:7
相关论文
共 30 条
  • [1] Goustin A.S., Leof E.B., Shipley G.D., Et al., Growth factors and cancer, Cancer Res, 46, pp. 1015-1029, (1986)
  • [2] Clark W.H., Elder D.E., Guerry D., Et al., A study of tumor progression: The precursor lesions of superficial spreading and nodular melanoma, Hum Pathol, 15, pp. 1147-1165, (1984)
  • [3] Becker D., Meier C.B., Herlyn M., Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor, EMBOJ, 8, pp. 3685-3691, (1989)
  • [4] Lu C., Vickers M.F., Kerbel R.S., Interleukin 6: A fibroblast-derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression, Proc Natl Acad Sci USA, 89, pp. 9215-9219, (1992)
  • [5] Lu C., Kerbel R.S., Interleukin 6: Transition from paracrine growth inhibitor to intracellular autocrine stimulator during human melanoma progression, J Cell Biol, 120, pp. 1281-1288, (1992)
  • [6] Albino A.P., Davis B.M., Nanus D.M., Induction of growth factor RNA expression in human malignant melanoma: Markers of transformation, Cancerres, 51, pp. 4815-4820, (1991)
  • [7] De Witt P.E., Moretti S., Koenders P.G., Et al., Increasing epidermal growth factor receptor expression in human melanocyte tumor progression, J Invest Dermatol, 99, pp. 168-173, (1992)
  • [8] Husain Z., Fitz G.G., Wick M.M., Comparison of cellular protooncogene activation and transformation-related activity of human melanocytes and metastatic melanoma, J Invest Dermatol, 95, pp. 571-575, (1990)
  • [9] Albino A.P., Nanus D.M., Mentle I.R., Analysis of Kras oncogenes in malignant melanoma and precursor lesions: Correlation of point mutations with differentiation phenotype, Oncogene, 4, pp. 1363-1374, (1989)
  • [10] Stretch J.R., Gatter K.C., Ralfkiaer E., Et al., Expression of mutant p53 in melanom, Cancer Res, 51, pp. 5976-5979, (1991)